Contact mechanics studies with the quartz crystal microbalance: origins of the contrast factor for polymer gels and solutions

A contact mechanics methodology utilizing the quartz crystal microbalance (QCM) has been applied to study the spreading behavior of polymer solutions and gels. Changes in the resonant frequency and in the dissipation are monitored as these materials are brought into contact with the electrode surface of the QCM. The primary application is in studies of elastic polymer gels, where spreading over the surface of the QCM is limited by the elasticity of the gel. Simultaneous measurement of the applied loads and displacements, along with measurement of the QCM/gel contact area, the frequency shift, and the dissipation, enable us to calibrate the QCM as a contact sensor. While changes in the frequency and dissipation both depend linearly on the contact area, measurements of the dissipation provide a more reliable indicator. The relationship between the dissipation and the contact area is determined by the solvent viscosity and by the high-frequency intrinsic viscosity of the system of interest. This result is consistent with previous results on the high-frequency rheological behavior of polymer solutions.     

QCM studies of gel spreading: Kraton gels on polystyrene surfaces

Contact of a polymer gel made from a styrene/ethylene-butene/styrene triblock copolymer in mineral oil was investigated by bringing the gel into contact with the coated surface of a quartz crystal microbalance (QCM). The experimental apparatus enabled simultaneous measurement of the load, displacement, and contact area, in addition to the resonant frequency and dissipation of the oscillating quartz crystal. The QCM response was determined by the linear viscoelastic properties of the gel at the frequency of oscillation. A geometric correction factor involving the contact area provided a means for quantitatively determining these viscoelastic parameters as the gel spread over the QCM surface. When the gel was removed from the surface, a thin solvent layer was left behind. The thickness of this solvent layer was determined from the QCM response and was compared to predictions from a simple model involving the disjoining pressure of the film and the osmotic pressure of the gel. Qualitative agreement with the model required that tensile, adhesive forces at the perimeter of the gel/QCM contact area were taken into account when calculating the film thickness.     

The role of the UPS in cystic fibrosis

CF is an inherited autosomal recessive disease whose lethality arises from malfunction of CFTR, a single chloride (Cl-) ion channel protein. CF patients harbor mutations in the CFTR gene that lead to misfolding of the resulting CFTR protein, rendering it inactive and mislocalized. Hundreds of CF-related mutations have been identified, many of which abrogate CFTR folding in the endoplasmic reticulum (ER). More than 70% of patients harbor the DeltaF508 CFTR mutation that causes misfolding of the CFTR proteins. Consequently, mutant CFTR is unable to reach the apical plasma membrane of epithelial cells that line the lungs and gut, and is instead targeted for degradation by the UPS. Proteins located in both the cytoplasm and ER membrane are believed to identify misfolded CFTR for UPS-mediated degradation. The aberrantly folded CFTR protein then undergoes polyubiquitylation, carried out by an E1-E2-E3 ubiquitin ligase system, leading to degradation by the 26S proteasome. This ubiquitin-dependent loss of misfolded CFTR protein can be inhibited by the application of 'corrector' drugs that aid CFTR folding, shielding it from the UPS machinery. Corrector molecules elevate cellular CFTR protein levels by protecting the protein from degradation and aiding folding, promoting its maturation and localization to the apical plasma membrane. Combinatory application of corrector drugs with activator molecules that enhance CFTR Cl- ion channel activity offers significant potential for treatment of CF patients. Publication history: Republished from Current BioData's Targeted Proteins database (TPdb; http://www.targetedproteinsdb.com).